PubMed

Disease prediction models aim to guide medical decision making.

Reynolds T.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):637-40. No abstract available. PMID: 11601944 [PubMed - indexed for MEDLINE]Related articlesFree article

Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.

Goldenberg VK, Seewaldt VL, Scott V, Bean GR, Broadwater G, Fabian C, Kimler B, Zalles C, Lipkus IM.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1032-4.PMID: 17507634 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.

Col NF, Goldberg RJ, Orr RK, Erban JK, Fortin JM, Chlebowski RT.

Med Decis Making. 2002 Sep-Oct;22(5):386-93.PMID: 12365480 [PubMed - indexed for MEDLINE]Related articles

How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.

McKay A, Martin W, Latosinsky S.

Breast Cancer Res Treat. 2005 Nov;94(2):153-9.PMID: 16261414 [PubMed - indexed for MEDLINE]Related articles

Another view of tamoxifen.

Napoli M.

Am J Nurs. 2001 Apr;101(4):33. No abstract available. PMID: 11301681 [PubMed - indexed for MEDLINE]Related articles

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.

Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S.

Cancer. 2005 May 15;103(10):1996-2005.PMID: 15825209 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.

Hershman D, Sundararajan V, Jacobson JS, Heitjan DF, Neugut AI, Grann VR.

J Clin Oncol. 2002 Jan 1;20(1):9-16.PMID: 11773148 [PubMed - indexed for MEDLINE]Related articles

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N.

J Natl Cancer Inst. 2003 Feb 19;95(4):302-7.PMID: 12591986 [PubMed - indexed for MEDLINE]Related articlesFree article

Tamoxifen for breast cancer among hysterectomised women.

Veronesi U, Maisonneuve P, Sacchini V, Rotmensz N, Boyle P; Italian Tamoxifen Study Group.

Lancet. 2002 Mar 30;359(9312):1122-4.PMID: 11943263 [PubMed - indexed for MEDLINE]Related articles

Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.

Duggan C, Marriott K, Edwards R, Cuzick J.

J Clin Oncol. 2003 Oct 1;21(19):3588-93.PMID: 14512389 [PubMed - indexed for MEDLINE]Related articles

USPSTF releases guidelines on breast-cancer chemoprevention.

Bradbury J.

Lancet. 2002 Jul 6;360(9326):63. No abstract available. PMID: 12114050 [PubMed - indexed for MEDLINE]Related articles

Tamoxifen. To take or not to take. That is the question.

Blanchard P.

Tex Nurs. 1999 Aug;73(7):4-5, 7. No abstract available. PMID: 11949057 [PubMed - indexed for MEDLINE]Related articles

Tamoxifen for breast cancer prevention: safety warning.

Wooltorton E.

CMAJ. 2002 Aug 20;167(4):378-9. Review. No abstract available. PMID: 12197698 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemoprevention of breast cancer.

Zelnak AB, O'Regan RM.

Curr Probl Cancer. 2004 Jul-Aug;28(4):201-17. Review. No abstract available. PMID: 15318323 [PubMed - indexed for MEDLINE]Related articles

Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.

Goldhaber SZ.

Circulation. 2005 Feb 8;111(5):539-41. No abstract available. PMID: 15699272 [PubMed - indexed for MEDLINE]Related articlesFree article

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.

Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM.

J Clin Oncol. 2004 Dec 15;22(24):4951-7. Epub 2004 Dec 14.PMID: 15598980 [PubMed - indexed for MEDLINE]Related articles

Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

Ménard S, Casalini P, Tagliabue E, Pupa SM, Balsari A.

J Natl Cancer Inst. 2003 Jun 18;95(12):917-8; author reply 918-9. No abstract available. PMID: 12813176 [PubMed - indexed for MEDLINE]Related articles

Update on breast cancer prevention.

Rastogi P, Vogel VG.

Oncology (Williston Park). 2003 Jun;17(6):799-805; discussion 808-10, 813. Review.PMID: 12846124 [PubMed - indexed for MEDLINE]Related articles

Chemoprevention of breast cancer.

Mahon SM.

Clin J Oncol Nurs. 2004 Aug;8(4):421-3. Review. No abstract available. PMID: 15354932 [PubMed - indexed for MEDLINE]Related articles

Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?

Bergh J.

Lancet. 2003 Jul 19;362(9379):183-4. No abstract available. PMID: 12885476 [PubMed - indexed for MEDLINE]Related articles